Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients (Q37612990)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients |
scientific article |
Statements
1 reference
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients (English)
1 reference
Julie H Ishida
Anita Patel
Jacqueline M McBride
Tracy Burgess
Michael A Derby
Brinda Emu
Becket Feierbach
Ashley E Fouts
Rong Deng
Carrie M Rosenberger
Lynn A Gennaro
Natalee S Striano
X Charlene Liao
Jorge A Tavel
21 November 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference